Lv2
144 积分 2023-12-06 加入
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
1个月前
已完结
Understanding the Functional Dependence and Inhibition of the Bcl-2 Pro-Survival Proteins in a Wide Spectrum of Cancers toward Precision Medicine
2个月前
已完结
Rapid, Operationally Simple, and Metal‐free NBS Mediated One‐pot Synthesis of 1,2‐Naphthoquinone from 2‐Naphthol
3个月前
已完结
Optimization of BAX trigger site activator BTSA1 with improved antitumor potency and in vitro ADMET properties
5个月前
已完结
Drug-Drug Interactions and Synergy: From Pharmacological Models to Clinical Application
5个月前
已完结
Inhibition of oligomeric BAX by an anti-apoptotic dimer
7个月前
已完结
Mechanistic Physiologically Based Pharmacokinetic Modeling of the Dissolution and Food Effect of a Biopharmaceutics Classification System IV Compound—The Venetoclax Story
7个月前
已完结
Asymmetric Construction of Bispiro‐Cyclopropane‐Pyrazolones via a [2+1] Cyclization Reaction by Dipeptide‐Based Phosphonium Salt Catalysis
11个月前
已完结
Lisaftoclax (APG-2575) Is a Novel BCL-2 Inhibitor with Robust Antitumor Activity in Preclinical Models of Hematologic Malignancy
1年前
已完结
β-Lactamase Inhibitors Derived from Single-Domain Antibody Fragments Elicited in the Camelidae
皖公网安备34019202002308
